866-997-4948(US-Canada Toll Free)

Global Polio Vaccine Market Insights,Forecast to 2025

Published By :

QYResearch

Published Date : Oct 2018

Category :

Pharmaceutical

No. of Pages : 116 Pages

This report studies the global market size of Polio Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Polio Vaccine in these regions.
This research report categorizes the global Polio Vaccine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The global average price of Polio Vaccine is in the increasing trend, from 497 USD/K doses in 2012 to 534 USD/K doses in 2016. With the situation of global economy and the IPV more and more popular, prices will be in increasing trend in the following five years.
The classification of Polio Vaccine includes Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV), and the revenue proportion of Inactivated Polio Vaccine (IPV) in 2016 is about 15.4%, and the proportion is in decreasing trend from 2012 to 2016.
In 2017, the global Polio Vaccine market size was 1210 million US$ and is forecast to 1830 million US in 2025, growing at a CAGR of 5.3% from 2018. The objectives of this study are to define, segment, and project the size of the Polio Vaccine market based on company, product type, application and key regions.

The various contributors involved in the value chain of Polio Vaccine include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Polio Vaccine include
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals

Market Size Split by Type
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
Market Size Split by Application
Public
Private

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Polio Vaccine market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Polio Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Polio Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Polio Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Polio Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Polio Vaccine are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (M Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Polio Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Polio Vaccine Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Polio Vaccine Market Size Growth Rate by Type
1.4.2 Inactivated Polio Vaccine (IPV)
1.4.3 Oral Polio Vaccine (OPV)
1.5 Market by Application
1.5.1 Global Polio Vaccine Market Size Growth Rate by Application
1.5.2 Public
1.5.3 Private
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Polio Vaccine Market Size
2.1.1 Global Polio Vaccine Revenue 2016-2025
2.1.2 Global Polio Vaccine Sales 2016-2025
2.2 Polio Vaccine Growth Rate by Regions
2.2.1 Global Polio Vaccine Sales by Regions
2.2.2 Global Polio Vaccine Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Polio Vaccine Sales by Manufacturers
3.1.1 Polio Vaccine Sales by Manufacturers
3.1.2 Polio Vaccine Sales Market Share by Manufacturers
3.1.3 Global Polio Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Polio Vaccine Revenue by Manufacturers
3.2.1 Polio Vaccine Revenue by Manufacturers (2016-2018)
3.2.2 Polio Vaccine Revenue Share by Manufacturers (2016-2018)
3.3 Polio Vaccine Price by Manufacturers
3.4 Polio Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Polio Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Polio Vaccine Product Category
3.4.3 Date of International Manufacturers Enter into Polio Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Polio Vaccine Sales by Type
4.2 Global Polio Vaccine Revenue by Type
4.3 Polio Vaccine Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Polio Vaccine Breakdown Data by Application

6 North America
6.1 North America Polio Vaccine by Countries
6.1.1 North America Polio Vaccine Sales by Countries
6.1.2 North America Polio Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Polio Vaccine by Type
6.3 North America Polio Vaccine by Application
6.4 North America Polio Vaccine by Company

7 Europe
7.1 Europe Polio Vaccine by Countries
7.1.1 Europe Polio Vaccine Sales by Countries
7.1.2 Europe Polio Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Polio Vaccine by Type
7.3 Europe Polio Vaccine by Application
7.4 Europe Polio Vaccine by Company

8 Asia Pacific
8.1 Asia Pacific Polio Vaccine by Countries
8.1.1 Asia Pacific Polio Vaccine Sales by Countries
8.1.2 Asia Pacific Polio Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Polio Vaccine by Type
8.3 Asia Pacific Polio Vaccine by Application
8.4 Asia Pacific Polio Vaccine by Company

9 Central & South America
9.1 Central & South America Polio Vaccine by Countries
9.1.1 Central & South America Polio Vaccine Sales by Countries
9.1.2 Central & South America Polio Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Polio Vaccine by Type
9.3 Central & South America Polio Vaccine by Application
9.4 Central & South America Polio Vaccine by Company

10 Middle East and Africa
10.1 Middle East and Africa Polio Vaccine by Countries
10.1.1 Middle East and Africa Polio Vaccine Sales by Countries
10.1.2 Middle East and Africa Polio Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Polio Vaccine by Type
10.3 Middle East and Africa Polio Vaccine by Application
10.4 Middle East and Africa Polio Vaccine by Company

11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Polio Vaccine
11.1.4 Polio Vaccine Product Description
11.1.5 Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Polio Vaccine
11.2.4 Polio Vaccine Product Description
11.2.5 Recent Development
11.3 Bibcol
11.3.1 Bibcol Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Polio Vaccine
11.3.4 Polio Vaccine Product Description
11.3.5 Recent Development
11.4 Serum Institute
11.4.1 Serum Institute Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Polio Vaccine
11.4.4 Polio Vaccine Product Description
11.4.5 Recent Development
11.5 Tiantan Biological
11.5.1 Tiantan Biological Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Polio Vaccine
11.5.4 Polio Vaccine Product Description
11.5.5 Recent Development
11.6 IMBCA
11.6.1 IMBCA Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Polio Vaccine
11.6.4 Polio Vaccine Product Description
11.6.5 Recent Development
11.7 Panacea Biotec Ltd
11.7.1 Panacea Biotec Ltd Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Polio Vaccine
11.7.4 Polio Vaccine Product Description
11.7.5 Recent Development
11.8 Bio-Med
11.8.1 Bio-Med Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Polio Vaccine
11.8.4 Polio Vaccine Product Description
11.8.5 Recent Development
11.9 Halfkin Bio-Pharmaceuticals
11.9.1 Halfkin Bio-Pharmaceuticals Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Polio Vaccine
11.9.4 Polio Vaccine Product Description
11.9.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Polio Vaccine Raw Material
13.1.2 Polio Vaccine Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Polio Vaccine
Figure Global Polio Vaccine Production (M Doses) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Polio Vaccine Production Market Share by Types (Product Category) in 2017
Figure Inactivated Polio Vaccine (IPV) Product Picture
Table Major Manufacturers of Inactivated Polio Vaccine (IPV)
Figure Oral Polio Vaccine (OPV) Product Picture
Table Major Manufacturers of Oral Polio Vaccine (OPV)
Table Global Polio Vaccine Market Size Growth Rate by Application 2018-2025 (M Doses)
Figure Public
Figure Private
Figure Polio Vaccine Report Years Considered
Figure Global Polio Vaccine Market Size 2016-2025 (Million US$)
Figure Global Polio Vaccine Sales 2016-2025 (M Doses)
Table Global Polio Vaccine Market Size by Regions 2016-2025 (M Doses) & (Million US$)
Table Global Polio Vaccine Sales by Regions 2016-2025 (M Doses)
Table Global Polio Vaccine Sales Market Share by Regions 2016-2025
Figure Global Polio Vaccine Sales Market Share by Regions 2016-2025
Figure 2017 Global Polio Vaccine Sales Market Share by Regions
Table Global Polio Vaccine Revenue by Regions 2016-2025 (Million US$)
Table Global Polio Vaccine Revenue Market Share by Regions 2016-2025
Figure Global Polio Vaccine Revenue Market Share by Regions 2016-2025
Figure 2017 Global Polio Vaccine Revenue Market Share by Regions
Table Global Polio Vaccine Sales by Manufacturers (2016-2018) (M Doses)
Table Global Polio Vaccine Sales Share by Manufacturers (2016-2018)
Figure Global Polio Vaccine Sales Share by Manufacturers in 2017
Table Polio Vaccine Revenue by Manufacturers (2016-2018) (Million US$)
Table Polio Vaccine Revenue Share by Manufacturers (2016-2018)
Figure Polio Vaccine Value Share by Manufacturers in 2017
Table Global Polio Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Polio Vaccine Price (2016-2018) (USD/K Doses)
Table Polio Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Polio Vaccine Product Category
Table Date of International Manufacturers Enter into Polio Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Polio Vaccine Sales by Type (2016-2025) (M Doses)
Table Global Polio Vaccine Sales Share by Type (2016-2025)
Figure Global Polio Vaccine Sales Market Share by Type (2016-2025)
Figure Global Polio Vaccine Sales Market Share by Type in 2017
Table Global Polio Vaccine Revenue by Type (2016-2025) (Million US$)
Table Global Polio Vaccine Revenue Share by Type (2016-2025)
Figure Global Polio Vaccine Revenue Market Share by Type (2016-2025)
Figure Global Polio Vaccine Revenue Market Share by Type in 2017
Table Polio Vaccine Price by Type 2013-2018 (USD/K Doses)
Table Global Polio Vaccine Sales by Application (2016-2025) (M Doses)
Table Global Polio Vaccine Sales Share by Application (2016-2025)
Figure Global Sales Polio Vaccine Market Share by Application (2016-2025)
Figure Global Sales Polio Vaccine Market Share by Application (2016-2025)
Figure North America Polio Vaccine Sales Growth Rate 2016-2025 (M Doses)
Figure North America Polio Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table North America Polio Vaccine Sales by Countries (2016-2025) (M Doses)
Table North America Polio Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 North America Polio Vaccine Sales Market Share by Countries
Table North America Polio Vaccine Revenue by Countries (2016-2025) (Million US$)
Table North America Polio Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Polio Vaccine Revenue Market Share by Countries
Figure United States Polio Vaccine Sales Growth Rate (2016-2025) (M Doses)
Figure United States Polio Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Polio Vaccine Sales Growth Rate (2016-2025) (M Doses)
Figure Canada Polio Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Polio Vaccine Sales Growth Rate (2016-2025) (M Doses)
Figure Mexico Polio Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table North America Polio Vaccine Sales by Type (2016-2025) (M Doses)
Table North America Polio Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 North America Polio Vaccine Market Share by Type
Table North America Polio Vaccine Sales by Application (2016-2025) (M Doses)
Table North America Polio Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 North America Polio Vaccine Market Share by Application
Table North America Polio Vaccine Sales by Company (2016-2018) (M Doses)
Table North America Polio Vaccine Sales Market Share by Company (2016-2018)
Figure North America Polio Vaccine Sales Market Share by Company in 2017
Figure Europe Polio Vaccine Sales Growth Rate 2016-2025 (M Doses)
Figure Europe Polio Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Polio Vaccine Sales by Countries (2016-2025) (M Doses)
Table Europe Polio Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Polio Vaccine Sales Market Share by Countries
Table Europe Polio Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Europe Polio Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Polio Vaccine Revenue Market Share by Countries
Figure Germany Polio Vaccine Sales Growth Rate (2016-2025) (M Doses)
Figure Germany Polio Vaccine Revenue Growth Rate (2016-2025) (M Doses)
Figure France Polio Vaccine Sales Growth Rate (2016-2025) (M Doses)
Figure France Polio Vaccine Revenue Growth Rate (2016-2025) (M Doses)
Figure UK Polio Vaccine Sales Growth Rate (2016-2025) (M Doses)
Figure UK Polio Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Polio Vaccine Sales Growth Rate (2016-2025) (M Doses)
Figure Italy Polio Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Polio Vaccine Sales Growth Rate (2016-2025) (M Doses)
Figure Russia Polio Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Polio Vaccine Sales by Type (2016-2025) (M Doses)
Table Europe Polio Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Europe Polio Vaccine Market Share by Type
Table Europe Polio Vaccine Sales by Application (2016-2025) (M Doses)
Table Europe Polio Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Europe Polio Vaccine Market Share by Application
Table Europe Polio Vaccine Sales by Company (2016-2018) (M Doses)
Table Europe Polio Vaccine Sales Market Share by Company (2016-2018)
Figure Europe Polio Vaccine Sales Market Share by Company in 2017
Figure Asia Pacific Polio Vaccine Sales Growth Rate 2016-2025 (M Doses)
Figure Asia Pacific Polio Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Polio Vaccine Sales by Countries (2016-2025) (M Doses)
Table Asia Pacific Polio Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Polio Vaccine Sales Market Share by Countries
Table Asia Pacific Polio Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Polio Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Polio Vaccine Revenue Market Share by Countries
Figure China Polio Vaccine Sales Growth Rate (2016-2025) (M Doses)
Figure China Polio Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Polio Vaccine Sales Growth Rate (2016-2025) (M Doses)
Figure Japan Polio Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Polio Vaccine Sales Growth Rate (2016-2025) (M Doses)
Figure Korea Polio Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure India Polio Vaccine Sales Growth Rate (2016-2025) (M Doses)
Figure India Polio Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Polio Vaccine Sales Growth Rate (2016-2025) (M Doses)
Figure Australia Polio Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Polio Vaccine Sales Growth Rate (2016-2025) (M Doses)
Figure Indonesia Polio Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Polio Vaccine Sales Growth Rate (2016-2025) (M Doses)
Figure Malaysia Polio Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Polio Vaccine Sales Growth Rate (2016-2025) (M Doses)
Figure Philippines Polio Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Polio Vaccine Sales Growth Rate (2016-2025) (M Doses)
Figure Thailand Polio Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Polio Vaccine Sales Growth Rate (2016-2025) (M Doses)
Figure Vietnam Polio Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Polio Vaccine Sales Growth Rate (2016-2025) (M Doses)
Figure Singapore Polio Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Polio Vaccine Sales by Type (2016-2025) (M Doses)
Table Asia Pacific Polio Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Polio Vaccine Market Share by Type
Table Asia Pacific Polio Vaccine Sales by Application (2016-2025) (M Doses)
Table Asia Pacific Polio Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Polio Vaccine Market Share by Application
Table Asia Pacific Polio Vaccine Sales by Company (2016-2018) (M Doses)
Table Asia Pacific Polio Vaccine Sales Market Share by Company (2016-2018)
Figure Asia Pacific Polio Vaccine Sales Market Share by Company in 2017
Figure Central & South America Polio Vaccine Sales Growth Rate 2016-2025 (M Doses)
Figure Central & South America Polio Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Polio Vaccine Sales by Countries (2016-2025) (M Doses)
Table Central & South America Polio Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Polio Vaccine Sales Market Share by Countries
Table Central & South America Polio Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Polio Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Polio Vaccine Revenue Market Share by Countries
Figure Brazil Polio Vaccine Sales Growth Rate (2016-2025) (M Doses)
Figure Brazil Polio Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Polio Vaccine Sales Growth Rate (2016-2025) (M Doses)
Figure Argentina Polio Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Polio Vaccine Sales by Type (2016-2025) (M Doses)
Table Central & South America Polio Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Polio Vaccine Market Share by Type
Table Central & South America Polio Vaccine Sales by Application (2016-2025) (M Doses)
Table Central & South America Polio Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Polio Vaccine Market Share by Application
Table Central & South America Polio Vaccine Sales by Company (2016-2018) (M Doses)
Table Central & South America Polio Vaccine Sales Market Share by Company (2016-2018)
Figure Central & South America Polio Vaccine Sales Market Share by Company in 2017
Figure Middle East and Africa Polio Vaccine Sales Growth Rate 2016-2025 (M Doses)
Figure Middle East and Africa Polio Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Polio Vaccine Sales by Countries (2016-2025) (M Doses)
Table Middle East and Africa Polio Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Polio Vaccine Sales Market Share by Countries
Table Middle East and Africa Polio Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Polio Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Polio Vaccine Revenue Market Share by Countries
Figure GCC Countries Polio Vaccine Sales Growth Rate (2016-2025) (M Doses)
Figure GCC Countries Polio Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Polio Vaccine Sales Growth Rate (2016-2025) (M Doses)
Figure Turkey Polio Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Polio Vaccine Sales Growth Rate (2016-2025) (M Doses)
Figure Egypt Polio Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Polio Vaccine Sales Growth Rate (2016-2025) (M Doses)
Figure South Africa Polio Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Polio Vaccine Sales by Type (2016-2025) (M Doses)
Table Middle East and Africa Polio Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Polio Vaccine Market Share by Type
Table Middle East and Africa Polio Vaccine Sales by Application (2016-2025) (M Doses)
Table Middle East and Africa Polio Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Polio Vaccine Market Share by Application
Table Middle East and Africa Polio Vaccine Sales by Company (2016-2018) (M Doses)
Table Middle East and Africa Polio Vaccine Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Polio Vaccine Sales Market Share by Company in 2017
Table Sanofi Company Details
Table Sanofi Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2018)
Table Sanofi Recent Development
Table GSK Company Details
Table GSK Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2018)
Table GSK Recent Development
Table Bibcol Company Details
Table Bibcol Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2018)
Table Bibcol Recent Development
Table Serum Institute Company Details
Table Serum Institute Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2018)
Table Serum Institute Recent Development
Table Tiantan Biological Company Details
Table Tiantan Biological Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2018)
Table Tiantan Biological Recent Development
Table IMBCA Company Details
Table IMBCA Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2018)
Table IMBCA Recent Development
Table Panacea Biotec Ltd Company Details
Table Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2018)
Table Panacea Biotec Ltd Recent Development
Table Bio-Med Company Details
Table Bio-Med Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2018)
Table Bio-Med Recent Development
Table Halfkin Bio-Pharmaceuticals Company Details
Table Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2018)
Table Halfkin Bio-Pharmaceuticals Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Polio Vaccine Value Chain
Table Typical Suppliers of Key Polio Vaccine Raw Material
Table Polio Vaccine Customers List
Table Polio Vaccine Sales Channels
Table Polio Vaccine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *